Improving risk perception and uptake of pre-exposure prophylaxis (PrEP) through interactive feedback-based counselling with and without community engagement in young women in Manicaland, East Zimbabwe: study protocol for a pilot randomized trial
File(s)ImprovingRiskPerceptionAndUptake.pdf (1.13 MB)
Published version
Author(s)
Type
Journal Article
Abstract
Background
HIV incidence in adolescent girls and young women remains high in sub-Saharan Africa. Progress
towards uptake of HIV prevention methods remains low. Studies of oral PrEP have shown that uptake
and adherence may be low due to low risk perception and ambivalence around using antiretrovirals
for prevention. No evidence exists on whether an interactive intervention aimed at adjusting risk
perception and addressing the uncertainty around PrEP will improve uptake. This pilot research trial
aims to provide an initial evaluation of the impact of an interactive digital tablet-based counselling
session, correcting risk perception and addressing ambiguity around availability, usability and
effectiveness of PrEP.
Methods/Design
This is a matched-cluster randomised controlled trial which will compare an interactive tablet-based
education intervention against a control with no intervention. The study will be implemented in eight
sites. In each site, two matched clusters of villages will be created. One cluster will be randomly
allocated to intervention. In two sites a community engagement intervention will also be implemented
to address social obstacles and to increase support from peers, families and social structures. 1,200
HIV-negative young women 18-24 years, not on PrEP at baseline will be eligible. Baseline measures of
endpoints will be gathered in surveys. Follow-up assessment at six months will include bio-markers of
PrEP uptake and surveys.
Discussion
This will be the first randomized controlled trial to determine whether interactive feedback
counselling leads to uptake of HIV prevention methods such as PrEP and reduces risky sexual
behaviour. If successful, policymakers could consider such an intervention in school-based education
campaigns or as post- HIV-testing counselling for young people.
Trial Registration
This trial has been registered on clinicaltrials.gov on 21/06/2018 (identifier: NCT03565575).
https://clinicaltrials.gov/ct2/show/NCT03565575
HIV incidence in adolescent girls and young women remains high in sub-Saharan Africa. Progress
towards uptake of HIV prevention methods remains low. Studies of oral PrEP have shown that uptake
and adherence may be low due to low risk perception and ambivalence around using antiretrovirals
for prevention. No evidence exists on whether an interactive intervention aimed at adjusting risk
perception and addressing the uncertainty around PrEP will improve uptake. This pilot research trial
aims to provide an initial evaluation of the impact of an interactive digital tablet-based counselling
session, correcting risk perception and addressing ambiguity around availability, usability and
effectiveness of PrEP.
Methods/Design
This is a matched-cluster randomised controlled trial which will compare an interactive tablet-based
education intervention against a control with no intervention. The study will be implemented in eight
sites. In each site, two matched clusters of villages will be created. One cluster will be randomly
allocated to intervention. In two sites a community engagement intervention will also be implemented
to address social obstacles and to increase support from peers, families and social structures. 1,200
HIV-negative young women 18-24 years, not on PrEP at baseline will be eligible. Baseline measures of
endpoints will be gathered in surveys. Follow-up assessment at six months will include bio-markers of
PrEP uptake and surveys.
Discussion
This will be the first randomized controlled trial to determine whether interactive feedback
counselling leads to uptake of HIV prevention methods such as PrEP and reduces risky sexual
behaviour. If successful, policymakers could consider such an intervention in school-based education
campaigns or as post- HIV-testing counselling for young people.
Trial Registration
This trial has been registered on clinicaltrials.gov on 21/06/2018 (identifier: NCT03565575).
https://clinicaltrials.gov/ct2/show/NCT03565575
Date Issued
2019-12-02
Date Acceptance
2019-10-05
Citation
Trials, 2019, 20 (1)
ISSN
1745-6215
Publisher
BioMed Central
Journal / Book Title
Trials
Volume
20
Issue
1
Copyright Statement
© The Author(s) 2019. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Sponsor
National Institute of Mental Health
Bill & Melinda Gates Foundation
National Institutes of Health
Medical Research Council (MRC)
National Institutes of Health
Grant Number
1R01MH114562-01
OPP1161471
1R01MH114562-01
MR/R015600/1
0000809659
Subjects
HIV prevention
Pre-exposure prophylaxis
Randomized trial
Zimbabwe
1102 Cardiorespiratory Medicine and Haematology
1103 Clinical Sciences
General & Internal Medicine
Cardiovascular System & Hematology
Publication Status
Published
Article Number
668